Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Geron Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Geron Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Geron Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Geron Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Geron Corp, Medical Devices Deals, 2012 to YTD 2018 9
Geron Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Geron Corp, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Geron Enters into Licensing Agreement with Janssen Pharmaceuticals for RNA Interference 11
GE Healthcare Expands Licensing Agreement With Geron For Stem Cell Assays 12
Equity Offering 13
Geron Plans to Raise up to USD250 Million in Public Offering of Securities 13
Geron to Raise up to USD100 Million in Public Offering of Shares 14
Geron Plans to Raise up to USD50 Million in Public Offering of Shares 15
Geron Completes Public Offering Of Shares For US$103.5 Million 16
Geron Announces Public Offering Of Shares For Up To US$50 Million 18
Asset Transactions 19
BioTime Completes Acquisition Of Stem Cell Assets From Geron 19
Geron Corp – Key Competitors 21
Geron Corp – Key Employees 22
Geron Corp – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Financial Announcements 24
Nov 01, 2018: Geron reports third quarter 2018 financial results and recent company events 24
Jul 31, 2018: Geron Reports Second Quarter 2018 Financial Results and Recent Company Events 26
May 10, 2018: Geron Reports First Quarter 2018 Financial Results 28
Mar 16, 2018: Geron Reports Fourth Quarter and Annual 2017 Financial Results and Recent Events 29
Nov 01, 2017: Geron Reports Third Quarter 2017 Financial Results 31
Aug 09, 2017: Geron Reports Second Quarter 2017 Financial Results 32
May 09, 2017: Geron Reports First Quarter 2017 Financial Results and Recent Events 33
Mar 01, 2017: Geron Reports Fourth Quarter and Annual 2016 Financial Results 35
Product News 37
12/12/2017: Geron Reports Imetelstat Presentations at American Society of Hematology Annual Meeting 37
11/01/2017: Janssen to Present Abstracts on Imetelstat at ASH 2017 39
06/18/2018: Geron Reports Imetelstat Oral Presentation at European Hematology Association Congress 41
05/17/2018: Geron Announces Oral Presentation at European Hematology Association Congress 43
Clinical Trials 44
Nov 20, 2017: Geron Announces First Patient Dosed in Expanded Part 1 of IMerge Clinical Trial in Myelodysplastic Syndromes 44
Oct 31, 2017: Geron Announces Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic Syndromes 45
Jul 31, 2017: Geron Announces Updates to Imetelstat Clinical Development 46
Apr 10, 2017: Geron Announces Completion of Second Internal Data Reviews for Imetelstat Trials Being Conducted by Janssen 47
Apr 05, 2017: Geron Reports Imetelstat Presentation at American Association for Cancer Research Annual Meeting 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50
Geron Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Geron Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Geron Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Geron Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Geron Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Geron Corp, Medical Devices Deals, 2012 to YTD 2018 10
Geron Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Geron Enters into Licensing Agreement with Janssen Pharmaceuticals for RNA Interference 12
GE Healthcare Expands Licensing Agreement With Geron For Stem Cell Assays 13
Geron Plans to Raise up to USD250 Million in Public Offering of Securities 14
Geron to Raise up to USD100 Million in Public Offering of Shares 15
Geron Plans to Raise up to USD50 Million in Public Offering of Shares 16
Geron Completes Public Offering Of Shares For US$103.5 Million 17
Geron Announces Public Offering Of Shares For Up To US$50 Million 19
BioTime Completes Acquisition Of Stem Cell Assets From Geron 20
Geron Corp, Key Competitors 22
Geron Corp, Key Employees 23
List of Figures
Geron Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Geron Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Geron Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Geron Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Geron Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Geron Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Geron Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Geron Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Geron Corp, Medical Devices Deals, 2012 to YTD 2018 10